Open-label Phase I/II Clinical Trial of SARS-CoV-2 Receptor Binding Domain-Tetanus Toxoid Conjugate Vaccine (FINLAY-FR-2) in Combination with Receptor Binding Domain-Protein Vaccine (FINLAY-FR-1A) in Children Rinaldo Puga-Gomez , Yariset Ricardo-Delgado , Chaumey Rojas-Iriarte , Leyanis Cespedes-Henriquez , Misleidys Piedra-Bello , Dania Vega-Mendoza , Noelvia Pestana Perez , Beatriz Paredes-Moreno , Meiby Rodriguez-Gonzalez , Carmen Valenzuela-Silva , Belinda Sanchez-Ramirez , Laura Rodriguez-Noda , Rocmira Perez-Nicado , Raul Gonzalez-Mugica , Tays Hernandez-Garcia , Talia Fundora-Barrios , Martha Dubet Echevarria , Juliet Maria Enriquez-Puertas , Yenicet Infante-Hernandez , Ariel Palenzuela-Diaz , Evelyn Gato-Orozco , Yanet Chappi-Estevez , Julio Cesar Francisco-Perez , Miladi Suarez-Martinez , Ismavy C. Castillo-Quintana , Sonsire Fernandez-Castillo , Yanet Climent-Ruiz , Darielys Santana-Mederos , Yanelda Garcia-Vega , Maria Eugenia Toledo-Romani , Delaram Doroud , Alireza Biglari , Yury Valdes-Balbin , Dagmar Garcia-Rivera , Vicente Verez-Bencomo International journal of infectious diseases（2023）
关键词
COVID-19, SARS-CoV-2, Conjugate vaccine, Pediatric vaccine, Heterologous scheme, Subunit vaccine, RBD vaccine
AI 理解论文
溯源树
样例
